Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-12-17 JOHNSON & JOHNSON 10% owner Sale −1,593 $7.58 $12K 1,342,094
2014-12-16 JOHNSON & JOHNSON 10% owner Sale −6,507 $7.63 $50K 1,343,687
2014-12-12 JOHNSON & JOHNSON 10% owner Sale −3,645 $7.51 $27K 1,350,194
2014-12-11 JOHNSON & JOHNSON 10% owner Sale −1,355 $7.50 $10K 1,353,839
2014-12-10 JOHNSON & JOHNSON 10% owner Sale −1,300 $7.70 $10K 1,355,194
2014-12-09 JOHNSON & JOHNSON 10% owner Sale −5,000 $7.73 $39K 1,356,494
2014-12-08 JOHNSON & JOHNSON 10% owner Sale −2,000 $7.69 $15K 1,361,494
2014-12-05 JOHNSON & JOHNSON 10% owner Sale −4,200 $7.78 $33K 1,363,494
2014-12-04 JOHNSON & JOHNSON 10% owner Sale −10,073 $7.76 $78K 1,367,694
2014-12-03 JOHNSON & JOHNSON 10% owner Sale −1,627 $7.75 $13K 1,377,767
2014-12-01 JOHNSON & JOHNSON 10% owner Sale −1,200 $7.54 $9K 1,379,394
2014-11-26 JOHNSON & JOHNSON 10% owner Sale −500 $7.60 $4K 1,380,594
2014-11-25 JOHNSON & JOHNSON 10% owner Sale −1,500 $7.80 $12K 1,381,094
2014-11-24 JOHNSON & JOHNSON 10% owner Sale −4,000 $8.02 $32K 1,382,594
2014-11-21 JOHNSON & JOHNSON 10% owner Sale −2,400 $8.25 $20K 1,386,594
2014-11-20 JOHNSON & JOHNSON 10% owner Sale −3,100 $8.21 $25K 1,388,994
2014-05-08 SHREWSBURY STEPHEN B CMO; Senior VP Clinical Dev. Grant or award · Stock Option (Right to Buy) +31,250 31,250
2014-05-08 Main David President and CEO Grant or award · Stock Option (Right to Buy) +65,000 65,000
2014-05-08 MacKenzie Lloyd VP Technical Operations Grant or award · Stock Option (Right to Buy) +25,000 25,000
2014-05-08 Alam Kamran CFO, Vice President Finance Grant or award · Stock Option (Right to Buy) +31,250 31,250

Page 23 of 27 · 537 trades